Natural and designer binding sites made by phage display technology.
about
Colicin biologyThe production of antibody fragments and antibody fusion proteins by yeasts and filamentous fungiStructural consequences of target epitope-directed functional alteration of an antibody. The case of anti-hen lysozyme antibody, HyHEL-10VH3 gene usage in neutralizing human antibodies specific for the Entamoeba histolytica Gal/GalNAc lectin heavy subunitRecombinant antibodies for cancer diagnosis and therapy.Selection of high affinity human neutralizing antibodies to VEGFR2 from a large antibody phage display library for antiangiogenesis therapy.An improved helper phage system for efficient isolation of specific antibody molecules in phage displayIdentification of CD4 and transferrin receptor antibodies by CXCR4 antibody-guided Pathfinder selection.Substrate specificity of human kallikrein 2 (hK2) as determined by phage display technology.Inhibition of Tat-mediated transactivation and HIV-1 replication by human anti-hCyclinT1 intrabodies.Affinity maturation of Fab antibody fragments by fluorescent-activated cell sorting of yeast-displayed libraries.Coiled coil miniprotein randomization on phage leads to charge pattern mimicry of the receptor recognition determinant of interleukin 5.Antibodies as therapeutic agents: vive la renaissance!The use of immunoliposome for nutrient target regulation (a review).Analysis of interactions of signaling proteins with phage-displayed ligands by fluorescence correlation spectroscopy.Selection of human antibody fragments directed against tumor T-cell epitopes for adoptive T-cell therapy.Phage-displayed combinatorial peptide libraries in fusion to beta-lactamase as reporter for an accelerated clone screening: Potential uses of selected enzyme-linked affinity reagents in downstream applications.Comparative analysis of human and mouse immunoglobulin variable heavy regions from IMGT/LIGM-DB with IMGT/HighV-QUEST.One-step detection of aflatoxin-B(1) using scFv-alkaline phosphatase-fusion selected from human phage display antibody library.In vitro methods for peptide display and their applications.Overview on the use of therapeutic antibodies in drug discovery.Selection of binding targets in parasites using phage-display and aptamer libraries in vivo and in vitro.Immunosensors for pesticide analysis: antibody production and sensor development.Enhancing in vitro selection techniques to assist the discovery, understanding and use of inorganic binding peptides.Lactobacillus helveticus MIMLh5-specific antibodies for detection of S-layer protein in Grana Padano protected-designation-of-origin cheese.scFv antibody: principles and clinical applicationDemystified...recombinant antibodies.Generation of 1E8 Single Chain Fv-Fc Construct Against Human CD59.Recombinant bispecific antibodies for cancer therapy.Screening specific polypeptides of breast cancer stem cells from a phage display random peptide library.Alphavbeta6 integrin in wound healing and cancer of the oral cavity.Development of novel drug delivery systems using phage display technology for clinical application of protein drugsHuman anti-ErbB2 immunoagents--immunoRNases and compact antibodies.Therapeutic antibodies: successes, limitations and hopes for the future.Continuing pursuit for ideal systemic anticancer radiotherapeutics.Engineered human IgG antibodies with longer serum half-lives in primates.The use of phage display to generate conformation-sensor recombinant antibodies.Antibody mimetic receptor proteins for label-free biosensors.Computational design of cyclic peptides for the customized oriented immobilization of globular proteins.PuLSE: Quality control and quantification of peptide sequences explored by phage display libraries.
P2860
Q24671701-08E354D5-564F-4B03-88C8-4E26E9DCD32EQ24800574-AE55F4DD-F196-4D4E-A70A-CFE3A22C51F9Q27641047-228392A7-3996-4C9D-B03B-2C9A1688E75FQ30452770-FA2FA238-6BE9-471D-AACA-4A9A53DB3344Q30771917-40E42ACC-1382-4009-BB40-5F20FAA639E5Q30790872-DA1AA176-87C1-4B62-A205-6D5C5CF4ACEBQ30818201-E8C8BEBE-D1E9-4A3F-A630-DF8418428A33Q31026565-A9A41C9B-3F82-4FF3-A0BC-BF20FBE15FE8Q31068008-CC43D52C-32DD-4B96-B083-AF3A8CD8BEA3Q31115718-91C0488A-C313-4204-A0E0-8C1FFE5FFAAFQ31148151-16D07CAE-68E4-4D40-A960-9302986B3499Q32064627-E14E1A5A-89E0-4B57-B347-4D4D80540F4EQ33193524-4388F2CF-BF25-4DE2-BD65-C73E1887915CQ33263078-26054DF9-0A16-45FB-A818-B37815950E24Q33364398-768256E4-C919-496C-AFAF-A81660D38DC0Q33368725-8BC4A488-6605-478A-ADCE-791AEEFBEED8Q33538843-4751AB52-F181-44F3-8201-AE09D56D6066Q33856759-FB55F0E2-712F-4DAC-8621-AB35AFBFE058Q33862881-7DA9DDCA-A9A9-44D2-AFD2-1E2B116CC4FFQ33917861-464DB7DE-E0CA-4C8B-AD65-414513B350DCQ34147273-859B39F6-6AF1-4024-A5CA-1076969B52E1Q34547148-E4A46A05-52E7-4308-BEA9-B6DB7760465EQ34604232-042ADB05-3308-426A-B114-164CE06C8043Q34760178-4D79DE3C-4840-46DD-872B-936FF2BE8B14Q35045102-1B08BAA6-AE92-43D2-BC39-DCAA4855276CQ35852647-A11B28F6-4ADF-4A7F-ABAB-A02C5B351921Q35873117-713AA0C7-AD21-4E86-BFA5-5A81D98EB17DQ35897605-3FD1BD91-F2CC-41D5-8FF6-323571790394Q36013830-2A510AC4-F0C8-478E-92DC-49B82EE1E88FQ36254809-0DD431CD-06CC-4E1F-A64E-40700799B95DQ36360521-06E03CCE-9E33-4FE2-A700-260A83004179Q37198453-F57D191F-4CC6-4456-BF3B-16312A349E35Q37394278-D64ED7FE-AFF9-4973-8628-3C6D50890CF2Q37491236-B33817C9-427E-4CBB-9428-0B79B33DF54DQ37946750-2EB91865-B9BE-4A7A-A6BB-883886CD2E46Q40603129-1CD6017D-47A0-4FCE-93B1-91880C39CB5EQ43090031-746BD006-27CE-44DD-9362-E025D682C6B3Q43855824-CDFE03F6-20E4-41C0-87FB-9F8F8EFA4536Q48050438-BF421521-2BF7-43E3-9D81-2E28525A1D77Q52374180-539B256F-B609-458A-9F61-896435D30975
P2860
Natural and designer binding sites made by phage display technology.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Natural and designer binding sites made by phage display technology.
@ast
Natural and designer binding sites made by phage display technology.
@en
type
label
Natural and designer binding sites made by phage display technology.
@ast
Natural and designer binding sites made by phage display technology.
@en
prefLabel
Natural and designer binding sites made by phage display technology.
@ast
Natural and designer binding sites made by phage display technology.
@en
P1433
P1476
Natural and designer binding sites made by phage display technology.
@en
P2093
Hoogenboom HR
P304
P356
10.1016/S0167-5699(00)01667-4
P577
2000-08-01T00:00:00Z